Log in

TSE:HSMHelius Medical Technologies Stock Price, Forecast & News

+0.01 (+1.49 %)
(As of 06/2/2020 01:13 AM ET)
Today's Range
Now: C$0.68
50-Day Range
MA: C$0.61
52-Week Range
Now: C$0.68
Volume11,000 shs
Average Volume28,851 shs
Market CapitalizationC$25.87 million
P/E RatioN/A
Dividend YieldN/A
Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, or acquiring noninvasive technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a medical device in Canada for the treatment of chronic balance deficit associated with a mild to moderate traumatic brain injury. Its PoNS device treats neurostimulation of cranial nerves via the tongue to restore lost function. Helius Medical Technologies, Inc. is headquartered in Newtown, Pennsylvania.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.54 out of 5 stars

Industry, Sector and Symbol

Industry Medical Devices



Sales & Book Value

Annual SalesC$1.03 million
Cash FlowC$0.10 per share
Book ValueC$0.14 per share



Market CapC$25.87 million
Next Earnings Date8/13/2020 (Estimated)
OptionableNot Optionable

Receive HSM News and Ratings via Email

Sign-up to receive the latest news and ratings for HSM and its competitors with MarketBeat's FREE daily newsletter.

Helius Medical Technologies (TSE:HSM) Frequently Asked Questions

How has Helius Medical Technologies' stock been impacted by COVID-19 (Coronavirus)?

Helius Medical Technologies' stock was trading at C$0.70 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, HSM stock has decreased by 2.9% and is now trading at C$0.68. View which stocks have been most impacted by Coronavirus.

When is Helius Medical Technologies' next earnings date?

Helius Medical Technologies is scheduled to release its next quarterly earnings announcement on Thursday, August 13th 2020. View our earnings forecast for Helius Medical Technologies.

How were Helius Medical Technologies' earnings last quarter?

Helius Medical Technologies Inc (TSE:HSM) announced its earnings results on Thursday, March, 12th. The company reported ($0.25) earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of ($0.28) by $0.03. The business had revenue of $0.20 million for the quarter, compared to analysts' expectations of $0.13 million. View Helius Medical Technologies' earnings history.

Has Helius Medical Technologies been receiving favorable news coverage?

News stories about HSM stock have been trending very positive on Tuesday, InfoTrie Sentiment Analysis reports. The research firm scores the sentiment of news coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Helius Medical Technologies earned a coverage optimism score of 3.5 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the company's share price in the next few days. View the latest news aboutHelius Medical Technologies.

Who are some of Helius Medical Technologies' key competitors?

What other stocks do shareholders of Helius Medical Technologies own?

Who are Helius Medical Technologies' key executives?

Helius Medical Technologies' management team includes the following people:
  • Mr. Philippe Deschamps, Chairman, CEO & Pres (Age 57)
  • Ms. Joyce N. LaViscount, CFO & COO (Age 57)
  • Ms. Jennifer Laux M.B.A., Chief Commercialization Officer (Age 52)
  • Dr. Jonathan Mark Sackier, Chief Medical Officer (Age 61)
  • Diane Carman, Sec.

What is Helius Medical Technologies' stock symbol?

Helius Medical Technologies trades on the Toronto Stock Exchange (TSX) under the ticker symbol "HSM."

How do I buy shares of Helius Medical Technologies?

Shares of HSM and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade, and Charles Schwab.

What is Helius Medical Technologies' stock price today?

One share of HSM stock can currently be purchased for approximately C$0.68.

How big of a company is Helius Medical Technologies?

Helius Medical Technologies has a market capitalization of C$25.87 million and generates C$1.03 million in revenue each year. Helius Medical Technologies employs 25 workers across the globe.

What is Helius Medical Technologies' official website?

The official website for Helius Medical Technologies is heliusmedical.com.

How can I contact Helius Medical Technologies?

The company can be reached via phone at 215-944-6100.

This page was last updated on 6/2/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.